NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

Gnawkz: Exquisite exposition from a shrewd operator of doing what sadly few have done (resulting in large loss of precious capital has impacted the shares in 2014) that removes lots of the time expiration issues since L has been reset; Direct results from MD Anderson appearing to be in conformity vs anecdotal updates; Direct expanding to UCLA; preparing Germany/UK ramping for eventual commercial rollout etc.

From the companies perspective HIGHEST PRIORITY is to deploy capital to get us over the BUSINESS hump vs the administration issues (CFO; IR etc) which will take place. Posters that perpetually harp on the latter, FAIL to understand: developing the business is first priority; employees are a close second; and last are shareholders! LP is qualified as a CFO but when she deems it appropriate will hire (note: altho late filings she still delivers without having to file for a second filing late extension!). Because the additional $'s expended on developing the business has multifold return opportunities and one time cost whereas the costs of a CFO/IR etc are ONGOING overhead costs. AND moreso for front end loaded capital intensive biotechs with NWBO being MALIGNED by influence peddling AF.

Followup note on Susquehanna Intl Holdings from Wikipedia:

Susquehanna International Group (SIG) is a privately held global investment, trading and technology firm servicing securities markets worldwide. SIG comprises a number of affiliated entities specializing in trading and proprietary investments in equities, fixed income, energy, commodity, index and derivative products, private equity and venture capital, research, customer trading and institutional sales. Susquehanna is probably best known for expertise in derivatives pricing and trading, especially equity options.
SIG is a specialist or DPM (designated primary market maker) in approximately 600 equity options and 45 index options on the CBOE, AMEX, PHLX, and ISE, including big name equities such as Google, Goldman Sachs, JP Morgan, GE, PepsiCo, and Microsoft and indices such as Nasdaq and Russell 2000 options.[1]

SIG's headquarters office is in Bala Cynwyd, a western suburb of Philadelphia, Pennsylvania, USA. The firm employs more than 1,500 people in offices across North America (New York, Chicago, San Francisco, Philadelphia, Boston), Australia (Sydney), Europe (Dublin), China (Shanghai, Beijing) and Hong Kong (Hong Kong). SIG is one of the largest employers in Lower Merion Township.[2]

To wit: Susquehanna Intl Holdings is the 8th largest instl holder of NWBO AND has ~$48 Bln well diversified portfolio!.

SUSQUEHANNA INTERNATIONAL GROUP, LLP Information
401 CITY AVENUE, SUITE 220, BALA CYNWYD, Pennsylvania, 19004, [phone]

Report Date: 09/30/2014

Position Statistics
Total Positions 4,560
New Positions 440
Increased Positions 2,073
Decreased Positions 2,449
Positions with Activity 4,522
Sold Out Positions 772
Total Mkt Value (in $ millions) 47,855

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting
Basic Materials 3.43%
Capital Goods 2.96%
Conglomerates 0.08%
Consumer Cyclical 3.79%
Consumer/Non-Cyclical 2.05%
Energy 4.54%
Financial 37.42%
Healthcare 6.75%
Services 16.2%
Technology 16.1%
Transportation 1.5%
Utilities 1.82%

My list of "Club of Ignores" is growing as logic,substance and depth of posts are lacking.